Three generations of α,γ-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes

[1]  R. Duncan,et al.  Dendrimer biocompatibility and toxicity. , 2005, Advanced drug delivery reviews.

[2]  Donald A Tomalia,et al.  Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.

[3]  G. Kokotos,et al.  Proline-modified poly(propyleneimine) dendrimers as catalysts for asymmetric aldol reactions , 2005 .

[4]  Mark W Tengowski,et al.  Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871 , 2005, Clinical Cancer Research.

[5]  A. Beezer,et al.  Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives , 2003 .

[6]  Mark W Grinstaff,et al.  Biodendrimers: new polymeric biomaterials for tissue engineering. , 2002, Chemistry.

[7]  G. Kokotos,et al.  Synthesis of Chiral n,n+1-Diamino Acids and their Application to the Construction of Dendrimers , 2002 .

[8]  R. Haag,et al.  Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.

[9]  J. Reek,et al.  Transition Metal Catalysis Using Functionalized Dendrimers. , 2001, Angewandte Chemie.

[10]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[11]  Dexi Liu,et al.  Synthesis of bifunctional cationic compound for gene delivery , 2001 .

[12]  R. Müller,et al.  Dendrimers in Diagnostics , 2000 .

[13]  F. Vögtle,et al.  Dendrimers: From Design to Application-A Progress Report. , 1999, Angewandte Chemie.

[14]  F. Diederich,et al.  Functional Dendrimers: Unique Biological Mimics , 1998 .

[15]  G. Kokotos,et al.  Synthesis and in vitro cytotoxicity of lipophilic platinum(II) complexes. , 1998, Bioorganic & medicinal chemistry letters.

[16]  Misset Jl.  Oxaliplatin in practice. , 1998 .

[17]  K. Sugita,et al.  Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma. , 1998, Anticancer research.

[18]  L. Kèlland,et al.  cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  D. Deforce,et al.  Synthesis and in vitro cytotoxicity of aminocoumarin platinum II complexes. , 1997 .

[20]  F. Vögtle,et al.  Dendritic Molecules: Concepts, Syntheses, Perspectives , 1996 .

[21]  L. Kèlland,et al.  Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. , 1993, Cancer research.

[22]  D. Hossfeld,et al.  Pharmacokinetic and Pharmacodynamic Study with Lobaplatin (D-19466), a New Platinum Complex, after Bolus Administration , 1992 .

[23]  F. Zunino,et al.  New Cisplatin Analogues—On the Way to Better Antitumor Agents , 1987 .

[24]  R. Bau,et al.  Spectroscopic studies and x-ray crystal structure determination of the complex cis-(S-ethylcysteine)platinum(II)dichloride , 1982 .

[25]  BARNETT ROSENBERG,et al.  Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode , 1965, Nature.

[26]  G. W. Anderson,et al.  The Use of Esters of N-Hydroxysuccinimide in Peptide Synthesis , 1964 .

[27]  Michele Peyrone.  Ueber die Einwirkung des Ammoniaks auf Platinchlorür , 1844 .